In a mouse model of Kabuki syndrome, resulting from deficiency in the H3K4 lysine methyltransferase KMT2D, HDAC inhibition with AR-42 rescued structural and functional brain deficits (56). This evidence concerns the gene KMT2D and Kabuki syndrome.